Warsaw, Ind.-based Zimmer Biomet Holdings Inc. won clearance from the U.S. FDA for its Rosa One spine system for robotically assisted minimally invasive and complex spine surgeries. "The clearance is meaningful as it further rounds out [Zimmer Biomet's] portfolio ahead of its full commercial launch in [the second half of 2019]," wrote Wells Fargo's Larry Biegelsen. He added that this latest application could serve as a big boost for the company, potentially contributing up to $15 million this year. Read More
